BACKGROUND: Spreading depolarization describes a near-complete electrical discharge with altered local cerebral blood flow. It is described in association with acute and chronic diseases like hemorrhagic stroke or migraine. Moyamoya vasculopathy is a chronic, progressive cerebrovascular disorder leading to cerebral hypoperfusion, hemodynamically insufficient basal collateralization, and increased cortical microvascularization. METHODS: In a prospective case series, we monitored for spontaneous spreading depolarization activity by using intraoperative laser speckle imaging for real-time visualization and measurement of cortical perfusion and cerebrovascular reserve capacity during cerebral revascularization in 4 consecutive patients with moyamoya. RESULTS: Spontaneous spreading depolarization occurrence was documented in a patient with moyamoya before bypass grafting. Interestingly, this patient also exhibited a marked preoperative increase in angiographic collateral vessel formation. CONCLUSIONS: The spontaneous occurrence of SDs in moyamoya vasculopathy could potentially provide an explanation for localized cortical infarction and increased cortical microvascular density in these patients.
BACKGROUND AND IMPORTANCE: This case highlights the effectiveness of endovascular balloon dilatation (percutaneous transluminal angioplasty (PTA)) for treating vasospasm in a radial artery (RA) bypass graft from the internal carotid artery to the M2 branch of the middle cerebral artery in a patient with severe subarachnoid hemorrhage. CLINICAL PRESENTATION: A 69-year-old woman with severe subarachnoid hemorrhage due to a ruptured giant aneurysm in the ophthalmic segment of the right internal carotid artery underwent an extracranial-intracranial high-flow bypass with a RA graft, followed by trapping of the aneurysm. During her intensive care unit stay, vasospasms developed primarily in the intracranial radial graft and M2 branches. These spasms showed only minimal improvement after standard care and intra-arterial vasospasmolysis with nimodipine. Thus, after systemic anticoagulation, balloon PTA was performed, treating both the intracranial and extracranial sections of the graft, including areas near the anastomosis. The procedure was complication-free, with immediate morphological success and significant improvement in perfusion to the middle cerebral artery territory. CONCLUSION: Endovascular balloon PTA should be considered a rescue measure for vasospasm in extracranial-intracranial bypasses, particularly with RA grafts post-SAH. Owing to its muscular structure, the RA graft is especially prone to spasm, potentially compromising graft patency. When pharmacological treatments fail, balloon PTA offers a targeted intervention to restore vessel caliber, stabilizing blood flow and preventing ischemic complications, thus supporting the bypass's long-term success.
Purpose: Stereotactic-guided biopsy remains the gold standard for diagnosing intracranial lesions not amenable to surgical resection. Frameless techniques, such as the VarioGuide® system (Brainlab AG, Munich, Germany), offer a minimally invasive alternative, typically using MRI-based navigation. However, MRI-based navigation may be affected by geometric distortions that impair targeting precision. CT imaging provides superior geometric fidelity. This retrospective analysis evaluates the accuracy of frameless stereotactic biopsies in clinical routine. Patients were grouped based on the imaging modality used for neuronavigation—either MRI-only or MRI-CT fusion—allowing secondary comparison between both approaches. Methods: In this retrospective cohort study, 99 patients who underwent frameless stereotactic biopsy between February 2022 and September 2024 were analysed. Patients were grouped by neuronavigation modality: CT-MRI fusion–based ( n = 18) and MRI-only ( n = 81). Accuracy was assessed by measuring entry and target deviations using postoperative CT. Lesion volume, depth, procedure duration, and complication rates were also evaluated. Results: Entry and targeting accuracy was comparable between groups (entry deviation: 5.2 ± 3.9 mm vs. 5.4 ± 3.0 mm, p = 0.84; target deviation: 4.2 ± 3.0 mm vs. 4.4 ± 2.7 mm, p = 0.85). Lesion volume and target depth showed no significant differences. No statistically significant differences in complication rates were observed between groups (27.8% vs. 11.1%, p = 0.14). Conclusion: MRI-only and CT-MRI fusion–based frameless stereotactic biopsies showed no statistically significant difference in targeting accuracy. While CT-based registration may theoretically reduce distortion-related errors, this was not reflected in our data. The choice of imaging modality should therefore be guided by clinical context and imaging availability. Further prospective studies are needed to clarify the value of CT integration in specific clinical scenarios.
RATIONALE AND OBJECTIVES: 3D-TOF-MRA is a standard non-invasive method for detecting and monitoring intracranial aneurysms, but long scan times remain a limitation. Compressed sensing (CS) acceleration for intracranial aneurysm evaluation has mainly been studied at 3T. This prospective single-center non-inferiority study compared CS-accelerated 3D-TOF at 1.5T with GRAPPA-accelerated 3D-TOF-MRA for evaluating untreated intracranial aneurysms. MATERIALS AND METHODS: Sample size was determined via a preliminary retrospective study. 25 patients with 32 untreated aneurysms underwent both CS- (factor 7, 3:04 min) and GRAPPA-accelerated (factor 2, 5:00 min) 3D-TOF, yielding a 38.7% scan-time reduction. Two blinded neuroradiologists assessed overall image quality (primary endpoint) and artifacts, subjective CNR, aneurysm delineation and diameters (secondary endpoints). Non-inferiority was tested via one-sided t-test (prespecified 10% margin); interrater agreement used ICC. RESULTS: CS demonstrated non-inferiority to GRAPPA for overall image quality in both readers (p ≤ .023), though interrater agreement was low (ICC 0.241–0.262), reflecting subjective variability. Secondary exploratory analyses showed heterogeneous preferences. ROI-based CNR was lower for CS (median 169.6; IQR, 91.0-226. vs. 278.2; 181.0-366.2). Aneurysm diameter measurements showed excellent interrater agreement for both techniques ( CS ICC, 0.899-0.980; GRAPPA ICC, 0.877-0.973; all p < .001). CONCLUSION: CS-accelerated 3D-TOF at 1.5T met non-inferiority criteria vs. GRAPPA-TOF for overall image quality, reducing scan time by 38.7% while preserving aneurysm measurement reliability. However, reduced CNR and reader-preference variability important trade-offs. These findings support the use of CS-accelerated-TOF as a time-efficient alternative to GRAPPA-accelerated-TOF in evaluating intracranial aneurysms, though further research on field-strength effects and small aneurysms is warranted.